pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Electra Therapeutics Inc · news · pharmadog
← back to Electra Therapeutics Inc
News mentioning Electra Therapeutics Inc
11
stories
9d
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
biospace
12d
Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitz
biospace
16d
Electra lights up with $350M IPO for pivotal immune-disease drug development
biospace
16d
This week in charts: GSK’s China deals, the $300M IPO club and selling the news
biopharma dive
17d
Inflammation biotech Electra charges up with $350M from upsized IPO
fiercebiotech
17d
Electra's $350M IPO will help it become a commercial biotech
endpoints
17d
Electra amasses $350M in biotech’s latest big IPO
biopharma dive
20d
Electra aims for nearly $300M IPO; Enhertu's Phase 3 lung cancer success
endpoints
21d
Electra aims for $342M IPO to power inflammatory drug’s push through phase 3
fiercebiotech
Aug 31, 26
Sanofi-backed Electra files for IPO to fund Phase 2/3 immunology drug
endpoints
Aug 31, 26
Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push
fiercebiotech
